Optimal site in the subthalamic nucleus for deep brain stimulation

Restricted access

The advent of deep brain stimulation (DBS) for individuals with the cardinal symptoms of medically intractable Parkinson disease (PD) was a major advance in the treatment of these desperate patients. Now, approximately a decade into the more routine use of this technology, reassessments of the methods and therapeutic efficacy of DBS are in order.

Although considerable worldwide experience has been gained in the application of this therapy, by contemporary standards we still lack a firm evidence base on which to definitively support the procedure. This deficit will be remedied, at least in part, by the findings of the Veterans Affairs–National

Article Information

© AANS, except where prohibited by US copyright law.

Headings

References

1

Benabid ALKoudsie ABenazzouz APiallat BKrack PLimousin-Dowsey P: Deep brain stimulation for Parkinson’s disease. Adv Neurol 86:4054122001

2

Plaha PBen-Shiomo YPatel KGill SS: Stimulation of the caudal zone incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 129:173217472006

3

Starr PFeiwell RMarks W Jr: Placement of deep brain stimulators into the subthalamic nucleus: technical approach. Stereotact Funct Neurosurg 72:2471999

4

Starr PA: Placement of deep brain stimulators into the subthalamic nucleus or Globus pallidus internus: technical approach. Stereotact Funct Neurosurg 79:1181452002

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 384 384 189
Full Text Views 504 504 8
PDF Downloads 34 34 4
EPUB Downloads 0 0 0

PubMed

Google Scholar